Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.15654159 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- <p>Measuring glucose uptake and inhibiting the enzymes alpha amylase, alpha glucosidase, and sucrase are examples of in vitro methods that can be used to evaluate the antidiabetic properties of synthetic or natural compounds. A test compound's ability to inhibit the alpha amylase enzyme indicates its antidiabetic action due to the digestive tract's inability to generate glucose. Alpha-glucose inhibitors can be regarded as oral antidiabetic medications because they lessen the effect of glucose on blood sugar. A high blood glucose level causes hemoglobin molecules to become glycated, and they stay that way. As a result, glycated hemoglobin estimation is an essential tool in the antidiabetic screening process. An essential technique for assessing antidiabetic properties is the reduction of such glucose uptake by yeast cells. The primary method to evaluate antidiabetic properties is the reduction of such glucose uptake by yeast cells. One of the key techniques for evaluating activity is cell culture, and the glucose diffusion assay is a simple diffusion method to assess the glucose transport in vitro.</p>